Department of Internal Medicine, Division of Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, The Netherlands.
Clin Immunol. 2012 Aug;144(2):83-6. doi: 10.1016/j.clim.2012.05.007. Epub 2012 May 24.
A patient presented with late onset disseminated nontuberculous mycobacterium (NTM) infection due to a novel interleukin-12/interleukin-23 receptor β1 (IL-12/IL-23Rβ1) mutation, r.1561C>G, leading to the amino acid substitution R521G. This is the second patient reported with a partial IL-12/IL-23Rβ1 defect.
一位患者出现了迟发性播散性非结核分枝杆菌(NTM)感染,这是由于一种新型白细胞介素 12/白细胞介素 23 受体 β1(IL-12/IL-23Rβ1)突变,即 r.1561C>G,导致氨基酸取代 R521G。这是第二位报道的具有部分 IL-12/IL-23Rβ1 缺陷的患者。